Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Elisabet de los Pinos, Ph.D., is the CEO of Aura Biosciences, Inc., a pioneering biopharmaceutical company focused on developing innovative therapies for cancer and rare diseases. Dr. de los Pinoss leadership is characterized by a deep commitment to scientific advancement, strategic growth, and patient-centered innovation. With a robust background in biotechnology and a track record of successful drug development, she has been instrumental in guiding Aura Biosciences through critical stages of research and clinical trials.
Dr. de los Pinos brings extensive experience from her previous roles in academia and industry, where she has demonstrated expertise in drug discovery and development. Her strategic vision has been pivotal in positioning Aura Biosciences at the forefront of cancer treatment innovation. Under her leadership, the company is advancing its proprietary technologies to deliver groundbreaking therapies with the potential to transform patient outcomes
